|Iacobas, Ionela -|
|Vats, Archana -|
|Hirschi, Karen -|
Submitted to: Arteriosclerosis Thrombosis and Vascular Biology
Publication Type: Review Article
Publication Acceptance Date: April 11, 2010
Publication Date: June 1, 2010
Citation: Iacobas, I., Vats, A., Hirschi, K.K. 2010. Vascular potential of human pluripotent stem cells. Arteriosclerosis Thrombosis and Vascular Biology. 30(6):1110-1117. Technical Abstract: Cardiovascular disease is the number one cause of death and disability in the US. Understanding the biological activity of stem and progenitor cells, and their ability to contribute to the repair, regeneration and remodeling of the heart and blood vessels affected by pathological processes is an essential part of the paradigm in enabling us to achieve a reduction in related deaths. Both human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are promising sources of cells for clinical cardiovascular therapies. Additional vitro studies are needed, to understand their relative phenotypes and molecular regulation toward cardiovascular cell fates. Further studies in translational animal models are also needed to gain insights into the potential, and function of both human ES- and iPS-derived cardiovascular cells, and enable translation from experimental, and preclinical studies to human trials.